We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 25

Privacy Commissioner’s decision set aside by the Federal Court

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • March 16 2015

A recent decision by Federal Court of Australia illustrated two things about privacy complaints - or at least those that end up before the courts:

Blockbuster drug goes bust? The Federal Court finds three AstraZeneca patents relating to Crestor (rosuvastatin) invalid

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • March 7 2013

In an important decision handed down on Tuesday, Justice Jagot of the Federal Court held that three patents relating to the blockbuster drug Crestor

Homeopathy plus! Not immune from the ACL

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • March 7 2013

On 21 February 2013, the ACCC instituted proceedings against Homeopathy Plus! Australia Pty Ltd ("Homeopathy Plus!") in the Federal Court of

Competition regulators continue their campaign against pharmaceutical companies

  • King & Wood Mallesons
  • -
  • Australia, USA
  • -
  • June 1 2011

Last month, the US Federal Trade Commission (FTC) released its findings on reverse payment settlements between pharmaceutical companies in the 2010 US fiscal year

European Commission ups the cost of paying for delay

  • King & Wood Mallesons
  • -
  • Australia, European Union, USA
  • -
  • August 13 2012

On 25 July 2012, the EC alleged that Danish pharmaceutical company Lundbeck violated EU antitrust rules by colluding to prevent other pharma companies from marketing generic versions of its best-seller antidepressant, citalopram

Australian case notes - Odisho v Bonazzi 2014 VSCA 11

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • May 20 2014

In this case the appellant, a patient who suffered a thromboembolic event following the use of tranexamic acid, claimed that her doctor had

Australian court decides important gene patenting question isolated genetic material patentable subject matter

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • February 15 2013

Earlier today, the Federal Court rejected a claim brought by Cancer Voices Australia that isolated genetic material (DNA or RNA) that is naturally

FWC supports employer’s right to nominate doctor

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • July 8 2014

The Fair Work Commission has ruled that an employer was entitled to require one of its employees to attend an appointment with a general practitioner

Experimental evidence comply with the rules or risk inadmissibility

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • March 22 2013

By refusing to allow Generic Health to adduce experimental evidence in a patent case currently being heard in the Federal Court, Justice Jagot has

The image of deception

  • King & Wood Mallesons
  • -
  • Australia
  • -
  • March 14 2014

On 10 March 2014, the Federal Court of Australia found that Breast Check Pty Ltd engaged in misleading or deceptive conduct and made false